Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19
Emre Yekedüz, Güngör Utkan, Yüksel Ürün
European Journal of Cancer (2020) Vol. 141, pp. 92-104
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence
Marina Treskova, Laura Haas, Sarah Reda, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 151
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy
Tommaso Morelli, Kohei Fujita, Gil Redelman‐Sidi, et al.
Thorax (2021) Vol. 77, Iss. 3, pp. 304-311
Open Access | Times Cited: 76
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review
Chiara Corti, Gabriele Antonarelli, Florian Scotté, et al.
Annals of Oncology (2021) Vol. 33, Iss. 2, pp. 158-168
Open Access | Times Cited: 70
SARS-CoV-2 vaccines for cancer patients: a call to action
Chiara Corti, Edoardo Crimini, Paolo Tarantino, et al.
European Journal of Cancer (2021) Vol. 148, pp. 316-327
Open Access | Times Cited: 63
Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
Shuting Han, Qingyuan Zhuang, Jianbang Chiang, et al.
BMJ Open (2022) Vol. 12, Iss. 2, pp. e044661-e044661
Open Access | Times Cited: 57
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
David J. Pinato, Lorenza Scotti, Alessandra Gennari, et al.
European Journal of Cancer (2021) Vol. 150, pp. 190-202
Open Access | Times Cited: 43
Mortality of COVID-19 in patients with hematological malignancies versus solid tumors: a systematic literature review and meta-analysis
Nicole Hardy, Charan Thej Reddy Vegivinti, Mansi Mehta, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 6, pp. 1945-1959
Open Access | Times Cited: 17
Immunogenicity and Safety of the Coronavac Vaccine in Patients with Cancer Receiving Active Systemic Therapy
Cengiz Karaçin, Tülay Eren, Esra Zeynelgil, et al.
Future Oncology (2021) Vol. 17, Iss. 33, pp. 4447-4456
Open Access | Times Cited: 38
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 33
Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)
Mathias Brügel, Léa Letrillart, Camille Evrard, et al.
European Journal of Cancer (2022) Vol. 166, pp. 8-20
Open Access | Times Cited: 22
Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center
Gisele Aparecida Fernandes, Diego Feriani, Ivan Leonardo Avelino França e Silva, et al.
Seminars in Oncology (2021) Vol. 48, Iss. 2, pp. 171-180
Open Access | Times Cited: 31
Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population‐based multistate cohort study including 4 618 377 adults in Catalonia, Spain
Elena Roel, Andrea Pistillo, Martina Recalde, et al.
International Journal of Cancer (2021) Vol. 150, Iss. 5, pp. 782-794
Open Access | Times Cited: 29
COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
L. Castelo-Branco, Z. Tsourti, Spyridon Gennatas, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100499-100499
Open Access | Times Cited: 21
Antibody response to a third booster dose of SARS-CoV-2 vaccination in adults with haematological and solid cancer: a systematic review
Youssra Al Hajji, Harriet Taylor, Thomas Starkey, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 10, pp. 1827-1836
Open Access | Times Cited: 20
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States
Ayodeji Adegunsoye, Rachel Baccile, Thomas J. Best, et al.
The Lancet Regional Health - Americas (2023) Vol. 25, pp. 100566-100566
Open Access | Times Cited: 10
Outcomes of COVID-19 and risk factors in patients with cancer
Manju Sengar, Girish Chinnaswamy, Priya Ranganathan, et al.
Nature Cancer (2022) Vol. 3, Iss. 5, pp. 547-551
Open Access | Times Cited: 17
Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study
Giulia Mentrasti, Luca Cantini, Clizia Zichi, et al.
The Oncologist (2022) Vol. 27, Iss. 9, pp. e723-e730
Open Access | Times Cited: 16
Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment
Alessio Amatu, Arianna Pani, Giorgio Patelli, et al.
European Journal of Cancer (2021) Vol. 163, pp. 16-25
Open Access | Times Cited: 21
The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants
Qing Wu, Shuimei Luo, Xianhe Xie
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Patients with cirrhosis during the COVID-19 pandemic: Current evidence and future perspectives
Hung-Yuan Su, Yin-Chou Hsu
World Journal of Clinical Cases (2021) Vol. 9, Iss. 13, pp. 2951-2968
Open Access | Times Cited: 18
Outcomes and Prognostic Factors in a Large Cohort of Hospitalized Cancer Patients With COVID-19
Guilherme Nader Marta, Renata Colombo Bonadio, Odeli Nicole Encinas Sejas, et al.
JCO Global Oncology (2021), Iss. 7, pp. 1084-1092
Open Access | Times Cited: 18
Outcomes of COVID-19 Patients under Cytotoxic Cancer Chemotherapy in Brazil
Mateus Bringel Oliveira Duarte, Frederico Leal, Juliana Luz Passos Argenton, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3490-3490
Open Access | Times Cited: 19
Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors
Benjamin Switzer, John B.A.G. Haanen, Paul Lorigan, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 7, pp. e002835-e002835
Open Access | Times Cited: 16
COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery
Maristella Bungaro, Francesco Passiglia, Giorgio V. Scagliotti
Biomedicines (2022) Vol. 10, Iss. 4, pp. 776-776
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top